These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9316529)

  • 1. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
    Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
    J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
    Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
    J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart.
    Böhm M; Diet F; Kemkes B; Erdmann E
    Klin Wochenschr; 1988 Oct; 66(19):957-62. PubMed ID: 2846949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure.
    Sigmund M; Jakob H; Becker H; Hanrath P; Schumacher C; Eschenhagen T; Schmitz W; Scholz H; Steinfath M
    Eur J Clin Pharmacol; 1996; 51(2):127-32. PubMed ID: 8911876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
    Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
    Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.
    Shaddy RE; Tani LY; Gidding SS; Pahl E; Orsmond GS; Gilbert EM; Lemes V
    J Heart Lung Transplant; 1999 Mar; 18(3):269-74. PubMed ID: 10328154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
    Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
    J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
    Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of positive inotropic phosphodiesterase III inhibitors.
    Honerjäger P
    Eur Heart J; 1989 Aug; 10 Suppl C():25-31. PubMed ID: 2553411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.
    DiLenarda A; Gregori D; Sinagra G; Lardieri G; Perkan A; Pinamonti B; Salvatore L; Secoli G; Zecchin M; Camerini F
    J Card Fail; 1996 Jun; 2(2):87-102. PubMed ID: 8798110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE
    Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
    Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
    Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.